Lu Han joined Lumira Capital’s Toronto office as an analyst in 2014. He focuses on new company formation and business due diligence and analyses on both public and private companies. He is also actively involved in process to identify unique projects with the potential to become disruptive companies and assists in fund raising initiatives.
Prior to joining Lumira, Lu was a co-founder and vice president, business strategy and operations, at Sound Options Tinnitus Treatment Inc., a startup company developing a personalized sound therapy to treat patients with chronic ringing in the ears. Prior to Sound Options, Lu had strategic consulting experience in the healthcare and life sciences sector, covering both Canadian and International markets. Lu received his Ph.D. in neuroscience from the Department of Physiology University of Toronto studying under Prof Michael Salter at Hospital for Sick Children (Sickkids). Lu holds a B.Sc. in medical sciences from Western University.
Lu is fluent in English and Mandarin Chinese.